These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10971335)

  • 1. Xeroderma pigmentosum: the role of phototesting.
    Stone N; Reed J; Mahood J; Hardwick N; George S
    Br J Dermatol; 2000 Sep; 143(3):595-7. PubMed ID: 10971335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythema action spectrum in xeroderma pigmentosum group A patients].
    Mitoh Y
    Nihon Hifuka Gakkai Zasshi; 1989 Jan; 99(1):9-14. PubMed ID: 2746965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and photobiological characteristics of Japanese xeroderma pigmentosum variant.
    Ichihashi M; Fujiwara Y
    Br J Dermatol; 1981 Jul; 105(1):1-12. PubMed ID: 7259973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum clinical practice guidelines.
    Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
    J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors.
    Yamashita T; Okura M; Ishii-Osai Y; Hida T
    J Dermatol; 2016 Oct; 43(10):1167-1173. PubMed ID: 26971583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xeroderma pigmentosum complementation group E: a case report.
    Kawada A; Satoh Y; Fujiwara Y
    Photodermatol; 1986 Aug; 3(4):233-8. PubMed ID: 3774595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xeroderma pigmentosum: recent clinical and photobiological aspects.
    Kondo S; Fukuro S; Nishioka K; Satoh Y
    J Dermatol; 1992 Nov; 19(11):690-5. PubMed ID: 1293156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The erythemal action spectrum and deoxyribonucleic acid repair synthesis in xeroderma pigmentosum.
    Ramsay CA; Giannelli F
    Br J Dermatol; 1975 Jan; 92(1):49-56. PubMed ID: 1156544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation.
    Itoh T; Linn S; Kamide R; Tokushige H; Katori N; Hosaka Y; Yamaizumi M
    J Invest Dermatol; 2000 Dec; 115(6):981-5. PubMed ID: 11121129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing and host cell reactivation assay lead to a diagnosis of xeroderma pigmentosum group D with mild ultraviolet radiation sensitivity.
    Sugaya M; Funamizu K; Kono M; Okuno Y; Kondo T; Ono R; Akiyama M; Nishigori C; Sato S
    J Dermatol; 2021 Jan; 48(1):96-100. PubMed ID: 32974964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum complementation group G--report of two cases.
    Norris PG; Hawk JL; Avery JA; Giannelli F
    Br J Dermatol; 1987 Jun; 116(6):861-6. PubMed ID: 3620347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema.
    Berg RJ; Ruven HJ; Sands AT; de Gruijl FR; Mullenders LH
    J Invest Dermatol; 1998 Apr; 110(4):405-9. PubMed ID: 9540983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeroderma pigmentosum: heterogeneous syndrome and model for UV carcinogenesis.
    Jung EG
    Bull Cancer; 1978; 65(3):315-21. PubMed ID: 719183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A whole family affected by xeroderma pigmentosum: clinical and genetic particularities].
    Zghal M; Fazaa B; Zghal A; Mokhtar I; Sarasin A; Kamoun MR; Gharbi MR
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):31-6. PubMed ID: 12605154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on 'xeroderma pigmentosum'.
    Fassihi H
    Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum in the United kingdom.
    Lehmann AR
    Photochem Photobiol; 2015; 91(2):484-5. PubMed ID: 24943090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum variant with multisystem involvement.
    Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
    Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.
    Kondo S; Mamada A; Miyamoto C; Keong CH; Satoh Y; Fujiwara Y
    Photodermatol; 1989 Apr; 6(2):89-95. PubMed ID: 2664729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.